crispr therapeutics stock

CRISPR Therapeutics Is a Top Pick for Piper Sandler. Now, it’s been accelerated. Shareholder percentage totals can add to more than 100% because some holders are included in the free float. That Would Open the Door to Curing Dozens of Other Diseases. It develops its products using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), a gene editing technology that allows for precise directed changes to genomic DNA. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. For the quarter, the company's collaboration revenue withered to roughly $148,000, from the year-ago figure of nearly $212 million. It has nothing to do with the COVID-19 crisis. It is also developing CTX110, a donor-derived gene-edited allogeneic CAR-T therapy targeting cluster of differentiation 19 positive malignancies. There are currently 2 sell ratings, 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Learn about financial terms, types of investments, trading strategies and more. Something went wrong while loading Watchlist. View analysts' price targets for CRISPR Therapeutics. Investors who anticipate trading during these times are strongly advised to use limit orders. 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRISPR Therapeutics in the last year. CRSP stock was sold by a variety of institutional investors in the last quarter, including NEA Management Company LLC, Columbus Circle Investors, WINTON GROUP Ltd, Patriot Financial Group Insurance Agency LLC, Nikko Asset Management Americas Inc., Ipswich Investment Management Co. Inc., Capital Investment Advisory Services LLC, and First Trust Advisors LP. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. CRISPR Therapeutics' mailing address is BAARERSTRASSE 14, ZUG V8, CH-6300. Privacy Notice, and Investors may trade in the Pre-Market (4:00-9:30 a.m. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Stock prices may also move more quickly in this environment. View which stocks have been most impacted by COVID-19. Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar? Disney, Lyft, DraftKings, Nikola, Palantir, and Other Stocks to Watch This Week, Fear is in the air, but here’s why investors could be looking at an ‘historic’ buying opportunity, Affordable Care Act goes before a reconstituted Supreme Court on Tuesday, Romney: Trump is ‘wrong to say that the election was rigged, corrupt and stolen’, Goldman Sachs cuts growth forecasts for the U.S. and Europe, citing worries over COVID-19’s winter spread, Covid-19 Infections Top 100,000 for the Fourth Day in a Row, President Bush says presidential election was conducted fairly and produced a clear outcome, Longtime ‘Jeopardy’ host Alex Trebek is dead at 80, Crispr Therapeutics started at buy with $110 stock price target at BofA Securities, Crispr Therapeutics upgraded to outperform from perform at Oppenheimer, Three Drug Stocks Get a Lift From Reports on Sickle-Cell Treatments, Crispr Therapeutics’ Gene-Edited Treatment Stopped Cancer in Some Patients, Charting a bull-trend pullback, S&P 500 retests gap support (3,500), Nobel Prize for Gene-Editing Innovators Boosts Crispr Therapeutics and Other Stocks, Crispr's stock shoots up after bullish call from BofA Securities analyst, Crisper Therapeutics shares decline on wider-than-expected loss, No one is interested in Cisco’s stock, but I am — and here’s why. Revenue) or per share (e.g. CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases. The Investor Relations website contains information about CRISPR Therapeutics's business for stockholders, potential investors, and financial analysts. That Would Open the Door to Curing Dozens of Other Diseases. Citigroup, Piper Jaffray and Barclays served as the underwriters for the IPO and Guggenheim Securities was co-manager. CRISPR Therapeutics employs 304 workers across the globe. var dom1 = document.querySelector('#form1783 #field1');var field1 = new LiveValidation(dom1, {validMessage: "", onlyOnBlur: false, wait: 300});field1.add(Validate.Presence, {failureMessage:"This field is required"});field1.add(Validate.Format, {pattern: /^([^@\s]+)@((?:[-a-z0-9]+\. AIM Trial Moves Ahead, And Other News: The Good, Bad And Ugly Of Biopharma, Top Analyst Upgrades and Downgrades: BigCommerce, Citrix, CRISPR, Dunkin, Fastly, Intel, Mattel, Pulte, Sirius, Southwest Air, Tesla, Under Armour and More, Vertex: Recent Clinical Setback Underscores The Need To Expand The Pipeline, CRISPR (CRSP) Falls Despite Positive Data on Lymphoma Study, Biotech Stock Roundup: BIIB Posts Q3 Results, VRTX Stops Study & Other Updates, Netflix, GSX Techedu leads premarket losers' pack, CRISPR Therapeutics under pressure after death reported in early-stage study on CAR T candidate, Bristol-Myers' Acquisition of Bluebird Seems to Make Sense, Healthcare And Biotech Outlook For The Rest Of 2020, Vertex: Looks Cheap, But I Have A Few Concerns, Vertex to End Phase II Study on AAT Deficiency Candidate, Needham sees upside for CRISPR Therapeutics with Q4 catalysts approaching, Crispr Therapeutics: Waiting On Early Data In 2H 2020, But The Clinical Pipeline Shows Promise (113% Upside), Sarepta: Leading The Genomic Medicine Pack. View analyst ratings for CRISPR Therapeutics. All rights reserved. Visit a quote page and your recently viewed tickers will be displayed here. Shares of CRSP can be purchased through any online brokerage account. Location*Please select…United StatesAfghanistanÅland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBolivia, Plurinational State ofBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCongo, the Democratic Republic of theCook IslandsCosta RicaCôte d'IvoireCroatiaCubaCuraçaoCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland Islands (Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly See (Vatican City State)HondurasHong KongHungaryIcelandIndiaIndonesiaIran, Islamic Republic ofIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People's Republic ofKorea, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyan Arab JamahiriyaLiechtensteinLithuaniaLuxembourgMacaoMacedonia, the former Yugoslav Republic ofMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesia, Federated States ofMoldova, Republic ofMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian Territory, OccupiedPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarReunionRomaniaRussian FederationRwandaSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint Maarten (Dutch part)SlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyrian Arab RepublicTaiwanTajikistanTanzania, United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVenezuela, Bolivarian Republic ofViet NamVirgin Islands (British)Virgin Islands, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabwe. Cody Willard shares a personal story that applies to the economy and investing. risk, allowing investors to make better decisions and streamline their work ow. According to data compiled by Yahoo! Have Watchlists? CRSP stock was acquired by a variety of institutional investors in the last quarter, including ARK Investment Management LLC, BlackRock Inc., State of Michigan Retirement System, Teacher Retirement System of Texas, California Public Employees Retirement System, Wells Fargo & Company MN, Hussman Strategic Advisors Inc., and DekaBank Deutsche Girozentrale. CRISPR Therapeutics' (NASDAQ: CRSP) stock took a hard hit when it disclosed on Oct. 21 that a patient in its Carbon phase 1 clinical trial for relapsed non-Hodgkin's lymphoma died unexpectedly earlier this month. Disney, Lyft, DraftKings, Nikola, Palantir, and Other Stocks to Watch This Week, Fear is in the air, but here’s why investors could be looking at an ‘historic’ buying opportunity, Affordable Care Act goes before a reconstituted Supreme Court on Tuesday, Romney: Trump is ‘wrong to say that the election was rigged, corrupt and stolen’, Goldman Sachs cuts growth forecasts for the U.S. and Europe, citing worries over COVID-19’s winter spread, Covid-19 Infections Top 100,000 for the Fourth Day in a Row, President Bush says presidential election was conducted fairly and produced a clear outcome, Longtime ‘Jeopardy’ host Alex Trebek is dead at 80, Crispr Therapeutics started at buy with $110 stock price target at BofA Securities, Crispr Therapeutics upgraded to outperform from perform at Oppenheimer, Three Drug Stocks Get a Lift From Reports on Sickle-Cell Treatments, Crispr Therapeutics’ Gene-Edited Treatment Stopped Cancer in Some Patients, Charting a bull-trend pullback, S&P 500 retests gap support (3,500), Nobel Prize for Gene-Editing Innovators Boosts Crispr Therapeutics and Other Stocks, Crispr's stock shoots up after bullish call from BofA Securities analyst, Crisper Therapeutics shares decline on wider-than-expected loss, No one is interested in Cisco’s stock, but I am — and here’s why.